Advanced Micro Devices, Inc. (AMD) Reaches $12.79 After 7.00% Up Move; Spectrum Pharmaceuticals (SPPI) Shorts Increased By 0.97%

May 16, 2018 - By Charlene Higgins

Advanced Micro Devices, Inc. (NASDAQ:AMD) Logo

The stock of Advanced Micro Devices, Inc. (NASDAQ:AMD) is a huge mover today! The stock increased 2.73% or $0.34 during the last trading session, reaching $12.79. About 41.36 million shares traded. Advanced Micro Devices, Inc. (NASDAQ:AMD) has declined 27.01% since May 16, 2017 and is downtrending. It has underperformed by 38.56% the S&P500.The move comes after 5 months positive chart setup for the $12.40 billion company. It was reported on May, 16 by Barchart.com. We have $13.69 PT which if reached, will make NASDAQ:AMD worth $867.86 million more.

Spectrum Pharmaceuticals Inc (NASDAQ:SPPI) had an increase of 0.97% in short interest. SPPI’s SI was 10.29 million shares in May as released by FINRA. Its up 0.97% from 10.19M shares previously. With 1.04 million avg volume, 10 days are for Spectrum Pharmaceuticals Inc (NASDAQ:SPPI)’s short sellers to cover SPPI’s short positions. The SI to Spectrum Pharmaceuticals Inc’s float is 17.44%. The stock increased 0.97% or $0.17 during the last trading session, reaching $17.7. About 348,165 shares traded. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) has risen 143.80% since May 16, 2017 and is uptrending. It has outperformed by 132.25% the S&P500.

Spectrum Pharmaceuticals, Inc. develops and commercializes oncology and hematology drug products. The company has market cap of $1.82 billion. The firm markets six drug products, including FUSILEV for patients with metastatic colorectal cancer and rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor to treat patients with relapsed or refractory PTCL; ZEVALIN injection for patients with follicular non-HodgkinÂ’s lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ injection for patients with relapsed or refractory PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients. It currently has negative earnings. It is also developing ROLONTIS for chemotherapy-induced neutropenia; QAPZOLA for intravesical instillation in post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer; and POZIOTINIB for treating breast and lung cancer.

Investors sentiment decreased to 1.63 in Q4 2017. Its down 1.21, from 2.84 in 2017Q3. It turned negative, as 26 investors sold Spectrum Pharmaceuticals, Inc. shares while 28 reduced holdings. 27 funds opened positions while 61 raised stakes. 78.22 million shares or 9.25% more from 71.60 million shares in 2017Q3 were reported. State Board Of Administration Of Florida Retirement holds 0% of its portfolio in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) for 63,394 shares. Louisiana State Employees Retirement, Louisiana-based fund reported 39,000 shares. Ameritas Invest Prtnrs Incorporated has 7,360 shares for 0.01% of their portfolio. Alphamark Advsrs Limited Liability has invested 0% in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Renaissance Tech Llc holds 6.18M shares or 0.13% of its portfolio. Goldman Sachs Gp Inc has 0.01% invested in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) for 1.86M shares. Teacher Retirement Systems Of Texas accumulated 28,560 shares. Price T Rowe Assoc Inc Md accumulated 17,686 shares or 0% of the stock. Numeric Invsts Limited reported 344,168 shares. Geode Mngmt Ltd has 811,847 shares for 0.01% of their portfolio. Fmr Ltd, Massachusetts-based fund reported 7.04 million shares. Legal General Gru Public Ltd Co invested 0% of its portfolio in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Voya Invest Management Ltd Com stated it has 64,564 shares. Blackrock Inc accumulated 15.99 million shares. Moreover, Great West Life Assurance Can has 0.01% invested in Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) for 116,735 shares.

More important recent Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) news were published by: Seekingalpha.com which released: “Spectrum Pharmaceuticals’ (SPPI) CEO Joe Turgeon on Q1 2018 Results – Earnings Call Transcript” on May 03, 2018, also Ocbj.com published article titled: “Midday Stock Roundup”, Nasdaq.com published: “Can These Top-Performing Biotech Stocks Keep Climbing?” on April 30, 2018. More interesting news about Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) was released by: Seekingalpha.com and their article: “Spectrum Pharmaceuticals: What To Expect From This Powerful Grower” with publication date: April 18, 2018.

Since March 21, 2018, it had 0 buys, and 21 insider sales for $16.52 million activity. $1.45 million worth of stock was sold by SHROTRIYA RAJESH C MD on Monday, May 7. 4,350 Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) shares with value of $71,123 were sold by GUSTAFSON KURT A. Krassner Stuart Mitchell also sold $78,278 worth of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) shares. Shares for $56,327 were sold by Turgeon Joseph W. on Thursday, March 22. Riga Thomas J sold $107,603 worth of stock.

Among 6 analysts covering Spectrum Pharma (NASDAQ:SPPI), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Spectrum Pharma had 14 analyst reports since August 7, 2015 according to SRatingsIntel. As per Wednesday, June 7, the company rating was maintained by Jefferies. H.C. Wainwright reinitiated Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) on Wednesday, August 16 with “Buy” rating. FBR Capital maintained Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) rating on Tuesday, April 10. FBR Capital has “Buy” rating and $2600 target. FBR Capital maintained the shares of SPPI in report on Monday, May 14 with “Buy” rating. The stock of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) earned “Hold” rating by Zacks on Thursday, August 27. Jefferies maintained the shares of SPPI in report on Friday, February 10 with “Buy” rating. The company was maintained on Thursday, November 5 by RBC Capital Markets. On Friday, August 7 the stock rating was maintained by RBC Capital Markets with “Outperform”. The firm has “Buy” rating by Jefferies given on Thursday, August 24. The stock of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) has “Buy” rating given on Friday, May 4 by H.C. Wainwright.

Among 32 analysts covering Advanced Micro (NASDAQ:AMD), 12 have Buy rating, 4 Sell and 16 Hold. Therefore 38% are positive. Advanced Micro had 123 analyst reports since August 13, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Macquarie Research on Monday, December 18. J.P. Morgan maintained Advanced Micro Devices, Inc. (NASDAQ:AMD) rating on Tuesday, May 30. J.P. Morgan has “Hold” rating and $11.5000 target. The firm has “Buy” rating by Canaccord Genuity given on Monday, July 24. Canaccord Genuity maintained Advanced Micro Devices, Inc. (NASDAQ:AMD) on Wednesday, February 1 with “Buy” rating. Bernstein downgraded Advanced Micro Devices, Inc. (NASDAQ:AMD) on Monday, October 30 to “Sell” rating. Stifel Nicolaus maintained the stock with “Hold” rating in Sunday, September 24 report. The rating was maintained by Credit Suisse with “Neutral” on Wednesday, January 31. The stock of Advanced Micro Devices, Inc. (NASDAQ:AMD) earned “Hold” rating by Craig Hallum on Thursday, April 7. The rating was maintained by Mizuho on Thursday, September 1 with “Neutral”. As per Tuesday, May 2, the company rating was downgraded by Macquarie Research.

Since December 11, 2017, it had 0 buys, and 18 sales for $21.58 million activity. 117,120 Advanced Micro Devices, Inc. (NASDAQ:AMD) shares with value of $1.41 million were sold by KUMAR DEVINDER. Papermaster Mark D had sold 100,000 shares worth $1.16 million on Tuesday, February 6. 75,000 shares valued at $752,250 were sold by ANDERSON JAMES ROBERT on Thursday, December 14. Shares for $725,625 were sold by Norrod Forrest Eugene on Wednesday, January 3. 75,046 shares valued at $906,556 were sold by WOLIN HARRY A on Monday, January 15. Shares for $2.18M were sold by Su Lisa T on Wednesday, February 14.

Advanced Micro Devices, Inc. operates as a semiconductor firm worldwide. The company has market cap of $12.40 billion. The Company’s primarily offers x86 microprocessors as an accelerated processing unit , chipsets, discrete graphics processing units (GPUs), and professional graphics; and server and embedded processors, and semi-custom System-on-Chip (SoC) products and technology for game consoles. It has a 319.75 P/E ratio. The firm provides x86 microprocessors for desktop PCs under the AMD A-Series, AMD E-Series, AMD FX CPU, AMD Athlon CPU and APU, AMD Sempron APU and CPU, and AMD Pro A-Series APU brands; and microprocessors for notebook and 2-in-1s under the AMD A-Series, AMD E-Series, AMD C-Series, AMD Z-Series, AMD FX APU, AMD Phenom, AMD Athlon CPU and APU, AMD Turion, and AMD Sempron APU and CPU brand names.

More notable recent Advanced Micro Devices, Inc. (NASDAQ:AMD) news were published by: Seekingalpha.com which released: “AMD: Is Growth About To Collapse?” on May 14, 2018, also Seekingalpha.com with their article: “AMD Joining The Self-Driving Car Race?” published on May 14, 2018, Nasdaq.com published: “World’s Largest Commercial PC Manufacturers Introduce AMD Ryzenâ„¢ PRO Mobile and Desktop APU Powered …” on May 14, 2018. More interesting news about Advanced Micro Devices, Inc. (NASDAQ:AMD) were released by: Fool.com and their article: “NVIDIA and AMD Have Resolved Their Long-Standing Cryptocurrency Conundrum” published on May 15, 2018 as well as Nasdaq.com‘s news article titled: “Sorry Advanced Micro Devices, Inc. Bears, 2018 Is a Breakout Year” with publication date: May 11, 2018.

Investors sentiment decreased to 1.09 in 2017 Q4. Its down 0.42, from 1.51 in 2017Q3. It worsened, as 79 investors sold Advanced Micro Devices, Inc. shares while 108 reduced holdings. 69 funds opened positions while 135 raised stakes. 577.22 million shares or 3.15% more from 559.57 million shares in 2017Q3 were reported. Oakbrook Ltd Com reported 0.05% stake. Parallax Volatility Advisers Lp invested in 22,489 shares or 0% of the stock. Bluefin Trading Ltd Liability Corp stated it has 18,611 shares. Riverhead Capital Mgmt Ltd Llc has 0.01% invested in Advanced Micro Devices, Inc. (NASDAQ:AMD) for 34,034 shares. Jacobs Levy Equity Mgmt holds 0.02% or 99,200 shares. Viking Fund Mgmt Ltd Liability Com holds 0.1% or 58,000 shares in its portfolio. Adage Capital Prtn Ltd Co holds 1.05M shares or 0.02% of its portfolio. Invesco holds 0.02% or 4.18 million shares. Moreover, Legal & General Grp Incorporated Public Limited Co has 0.03% invested in Advanced Micro Devices, Inc. (NASDAQ:AMD). Kentucky Retirement stated it has 0.04% in Advanced Micro Devices, Inc. (NASDAQ:AMD). Sumitomo Mitsui Tru Inc holds 0.03% of its portfolio in Advanced Micro Devices, Inc. (NASDAQ:AMD) for 2.29 million shares. Jane Street Gp Limited invested in 253,014 shares or 0.01% of the stock. Ameritas Inv Prns stated it has 0.01% of its portfolio in Advanced Micro Devices, Inc. (NASDAQ:AMD). Bank & Trust Of Hawaii has 25,990 shares. State Of Alaska Department Of Revenue has 0.04% invested in Advanced Micro Devices, Inc. (NASDAQ:AMD) for 153,970 shares.

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: